The AAM’s Giuseppe Randazzo warns that the generics business could become unsustainable in the future if the market dynamics ...

EMD Serono has partnered the Trump administration to expand access to the company’s in vitro fertilisation (IVF) therapies.

ZETA’s digital solutions enable pharmaceutical and biotech companies to accelerate innovation, streamline operations, and ...

Novo Nordisk will now run a Phase III trial for Omeros' former lead asset, zaltenibart in rare blood disorder, PNH.

With a legacy rooted in global scientific excellence, Sweden is quietly building one of Europe’s most dynamic biotech ...

Tubulis has completed a Series C, securing €308m ($361m) to be directed towards advancing clinical development of its ADC ...

A consortium led by Nordic Capital and Permira has raised its bid, though certain shareholder stances remain firm.

Oceanpine Capital is to acquire an 80% equity stake in Beijing Jacoray Pharmaceutical Technology for 200m yuan ($28m).

The WHO calls for increased policy focus on neurological disorders like Alzheimer’s disease, an indication that has seen ...

"Meanwhile, Goldman Sachs led by value but faced close competition from JP Morgan. The investment banks had their own notable ...

Kirkland & Ellis has secured the foremost position as a legal adviser in the mergers and acquisitions (M&A) sector in terms ...